#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	4624	16S	1529	1529	100.0	16S.l6.c17.ctg.1	2457	555.0	1	SNP	n	C1184T	0	.	.	1184	1184	C	1636	1636	C	680	C,A	611,2	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	7356	23S	2890	2890	99.86	23S.l6.c4.ctg.1	4086	539.7	0	.	n	.	0	T695C	SNP	695	695	T	1300	1300	C	547	C	475	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	7356	23S	2890	2890	99.86	23S.l6.c4.ctg.1	4086	539.7	0	.	n	.	0	G1337A	SNP	1337	1337	G	1942	1942	A	638	A	576	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	7356	23S	2890	2890	99.86	23S.l6.c4.ctg.1	4086	539.7	0	.	n	.	0	T1971C	SNP	1971	1971	T	2576	2576	C	722	C,A	651,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	7356	23S	2890	2890	99.86	23S.l6.c4.ctg.1	4086	539.7	1	SNP	n	C2597T	1	C2597T	SNP	2597	2597	C	3202	3202	T	609	T	546	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	7356	23S	2890	2890	99.86	23S.l6.c4.ctg.1	4086	539.7	1	SNP	n	A2045G	0	.	.	2045	2045	A	2650	2650	A	733	A,T,C	662,1,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
folP.WHO_P_01364c	folP.WHO_P_01364c	1	1	27	732	folP	852	852	100.0	folP.l15.c4.ctg.1	1937	112.6	1	SNP	p	R228S	1	.	.	682	684	AGC	1183	1185	AGC	155;155;156	A;G;C,A	142;137;136,1	folP.WHO_P_01364c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	1414	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3794	111.4	1	SNP	p	S91F	0	.	.	271	273	TCC	773	775	TCC	128;127;128	T;C,A;C	116;113,1;116	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	1414	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3794	111.4	1	SNP	p	D95N	0	.	.	283	285	GAC	785	787	GAC	128;128;128	G,T;A;C	117,1;116;118	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	1414	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3794	111.4	1	SNP	p	D95G	0	.	.	283	285	GAC	785	787	GAC	128;128;128	G,T;A;C	117,1;116;118	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_L_00489c	mtrR.WHO_L_00489c	1	1	27	638	mtrR	633	633	99.84	mtrR.l15.c4.ctg.1	1846	103.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	420	mtrR_promoter	250	250	99.6	mtrR_promoter.l6.c4.ctg.1	1418	88.7	0	.	n	.	0	C187G	SNP	187	187	C	775	775	G	157	G	143	.	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	1554	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3471	134.1	1	SNP	p	D86N	0	.	.	256	258	GAC	891	893	GAC	188;187;187	G;A;C	168;157;167	parC.WHO_P_00203c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	1554	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3471	134.1	1	SNP	p	S87I	0	.	.	259	261	AGT	894	896	AGT	188;188;188	A;G;T,G	161;168;166,1	parC.WHO_P_00203c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	1554	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3471	134.1	1	SNP	p	S87W	0	.	.	259	261	AGT	894	896	AGT	188;188;188	A;G;T,G	161;168;166,1	parC.WHO_P_00203c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	1554	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3471	134.1	1	SNP	p	S87R	0	.	.	259	261	AGT	894	896	AGT	188;188;188	A;G;T,G	161;168;166,1	parC.WHO_P_00203c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	1554	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3471	134.1	1	SNP	p	S88P	0	.	.	262	264	TCC	897	899	TCC	189;190;194	T;C;C	166;166;169	parC.WHO_P_00203c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	1318	parE	1986	1986	100.0	parE.l15.c4.ctg.1	3233	122.0	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1898	1900	GGC	137;138;139	G;G,T;C,A	124;125,1;121,1	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.2.001	penA.2.001	1	1	27	1140	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2827	120.8	1	SNP	p	A311V	0	.	.	931	933	GCA	1510	1512	GCA	172;172;170	G;C,T;A,C	154;154,1;148,1	penA.2.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	1140	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2827	120.8	1	SNP	p	I312M	0	.	.	934	936	ATC	1513	1515	ATC	170;170;170	A;T;C	156;154;153	penA.2.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	1140	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2827	120.8	1	SNP	p	V316T	0	.	.	946	948	GTG	1525	1527	GTG	170;171;173	G;T;G	151;150;155	penA.2.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	1140	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2827	120.8	1	SNP	p	V316P	0	.	.	946	948	GTG	1525	1527	GTG	170;171;173	G;T;G	151;150;155	penA.2.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	1140	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2827	120.8	1	SNP	p	T484S	0	.	.	1450	1452	ACC	2029	2031	ACC	135;135;135	A,C;C,G;C	116,1;117,1;117	penA.2.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	1140	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2827	120.8	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2083	2085	GCG	131;130;130	G;C,A;G	114;99,1;102	penA.2.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	1140	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2827	120.8	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2083	2085	GCG	131;130;130	G;C,A;G	114;99,1;102	penA.2.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	1140	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2827	120.8	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2206	2208	GGC	125;127;127	G,C;G,C;C	108,1;114,1;110	penA.2.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	1140	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2827	120.8	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2215	2217	GGC	125;125;125	G;G;C,G	102;110;109,1	penA.2.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	1140	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2827	120.8	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2233	2235	CCG	130;131;131	C;C;G	106;112;105	penA.2.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	1462	ponA	2397	2397	99.96	ponA.l6.c4.ctg.1	3505	125.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	860	porA	1146	1146	99.83	porA.l15.c4.ctg.1	2323	111.1	0	.	p	.	0	M83fs	FSHIFT	247	247	A	850	850	C	150	C	130	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	124	porB1a	984	175	90.5	porB1a.l6.c30.ctg.1	1689	21.3	0	.	p	.	0	H217N	NONSYN	649	651	CAT	1539	1541	AAT	13;13;13	A;A;T	13;12;11	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	124	porB1a	984	175	90.5	porB1a.l6.c30.ctg.1	1689	21.3	0	.	p	.	0	D218N	NONSYN	652	654	GAT	1542	1544	AAT	13;13;13	A;A;T	12;13;10	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	124	porB1a	984	175	90.5	porB1a.l6.c30.ctg.1	1689	21.3	0	.	p	.	0	A222V	NONSYN	664	666	GCT	1554	1556	GTT	13;13;12	G;T;T	12;13;12	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	124	porB1a	984	175	90.5	porB1a.l6.c30.ctg.1	1689	21.3	0	.	p	.	0	V226A	NONSYN	676	678	GTA	1566	1568	GCA	11;11;11	G;C;A	10;9;10	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	124	porB1a	984	175	90.5	porB1a.l6.c30.ctg.1	1689	21.3	0	.	p	.	0	.	MULTIPLE	700	702	ACT	1589	1591	GTA	11;11;11	G;T;A	8;8;10	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	124	porB1a	984	175	90.5	porB1a.l6.c30.ctg.1	1689	21.3	0	.	p	.	0	N237fs	FSHIFT	709	709	A	1598	1598	A	10	A	9	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	808	porB1b	1047	1047	96.57	porB1b.l15.c30.ctg.1	1968	121.7	0	.	p	.	0	G38E	NONSYN	112	114	GGA	694	696	GAA	153;154;154	G;A,C;A	135;135,1;139	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	808	porB1b	1047	1047	96.57	porB1b.l15.c30.ctg.1	1968	121.7	0	.	p	.	0	S46G	NONSYN	136	138	AGC	718	720	GGC	148;149;149	G;G;C	133;136;134	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	808	porB1b	1047	1047	96.57	porB1b.l15.c30.ctg.1	1968	121.7	0	.	p	.	0	E48G	NONSYN	142	144	GAA	724	726	GGA	150;150;150	G;G;A	134;133;136	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	808	porB1b	1047	1047	96.57	porB1b.l15.c30.ctg.1	1968	121.7	0	.	p	.	0	T87A	NONSYN	259	261	ACT	841	843	GCT	157;157;158	G;C;T	142;143;137	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	808	porB1b	1047	1047	96.57	porB1b.l15.c30.ctg.1	1968	121.7	0	.	p	.	0	T89S	NONSYN	265	267	ACC	847	849	AGC	160;160;161	A,G;G,C;C	144,1;145,1;145	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	808	porB1b	1047	1047	96.57	porB1b.l15.c30.ctg.1	1968	121.7	0	.	p	.	0	.	MULTIPLE	358	359	AA	939	940	CG	149;147	C;G	141;137	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	808	porB1b	1047	1047	96.57	porB1b.l15.c30.ctg.1	1968	121.7	0	.	p	.	0	.	MULTIPLE	361	362	GA	942	944	CAG	147;147;147	C;A;G	137;137;135	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	808	porB1b	1047	1047	96.57	porB1b.l15.c30.ctg.1	1968	121.7	0	.	p	.	0	N122K	NONSYN	364	366	AAC	946	948	AAA	146;146;146	A;A;A,C	134;134;134,1	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	808	porB1b	1047	1047	96.57	porB1b.l15.c30.ctg.1	1968	121.7	0	.	p	.	0	K143E	NONSYN	427	429	AAA	1009	1011	GAA	141;141;142	G;A,G;A	129;127,1;127	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	808	porB1b	1047	1047	96.57	porB1b.l15.c30.ctg.1	1968	121.7	0	.	p	.	0	V151A	NONSYN	451	453	GTA	1033	1035	GCA	139;139;139	G,A;C;A	124,1;127;124	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	808	porB1b	1047	1047	96.57	porB1b.l15.c30.ctg.1	1968	121.7	0	.	p	.	0	Q187R	NONSYN	559	561	CAA	1141	1143	CGA	139;139;138	C;G;A	128;129;130	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	808	porB1b	1047	1047	96.57	porB1b.l15.c30.ctg.1	1968	121.7	0	.	p	.	0	A215T	NONSYN	643	645	GCT	1225	1227	ACT	142;142;140	A,T,C;C;T	130,1,1;126;125	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	808	porB1b	1047	1047	96.57	porB1b.l15.c30.ctg.1	1968	121.7	0	.	p	.	0	Y216H	NONSYN	646	648	TAT	1228	1230	CAT	139;138;139	C;A;T	128;129;128	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	808	porB1b	1047	1047	96.57	porB1b.l15.c30.ctg.1	1968	121.7	0	.	p	.	0	I218M	NONSYN	652	654	ATA	1234	1236	ATG	142;143;144	A;T;G,A	134;134;134,1	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	808	porB1b	1047	1047	96.57	porB1b.l15.c30.ctg.1	1968	121.7	0	.	p	.	0	.	MULTIPLE	766	767	AC	1348	1350	GCA	166;165;164	G;C;A	147;145;145	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	808	porB1b	1047	1047	96.57	porB1b.l15.c30.ctg.1	1968	121.7	0	.	p	.	0	W257R	NONSYN	769	771	TGG	1352	1354	CGG	163;163;163	C;G;G	146;147;145	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	808	porB1b	1047	1047	96.57	porB1b.l15.c30.ctg.1	1968	121.7	0	.	p	.	0	S258fs	FSHIFT	772	772	A	1355	1355	A	162	A	144	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	808	porB1b	1047	1047	96.57	porB1b.l15.c30.ctg.1	1968	121.7	1	SNP	p	G120K	1	.	.	358	360	AAG	939	941	CGG	149;147;148	C;G;G	141;137;137	porB1b.WHO_L_01891c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	808	porB1b	1047	1047	96.57	porB1b.l15.c30.ctg.1	1968	121.7	1	SNP	p	A121D	1	.	.	361	363	GAC	942	945	CGC	147;147;147	C;G;C	137;135;138	porB1b.WHO_L_01891c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	808	porB1b	1047	1047	96.57	porB1b.l15.c30.ctg.1	1968	121.7	1	SNP	p	D121N	0	.	.	361	363	GAC	942	945	CGC	147;147;147	C;G;C	137;135;138	porB1b.WHO_L_01891c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	2796	rpoB	4179	4179	100.0	rpoB.l15.c4.ctg.1	5468	153.4	1	SNP	p	H553N	1	.	.	1657	1659	AAT	2260	2262	AAT	158;158;158	A;A;T,G	142;145;138,1	rpoB.WHO_M_02157:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	494	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1631	90.8	1	SNP	p	V57M	1	.	.	169	171	ATG	845	847	ATG	165;164;163	A;T;G	155;152;151	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
